Recently, PuffBar e-cigarettes and similar products have emerged on the market claiming to contain synthetic nicotine – nicotine that is not derived from tobacco, but instead produced in a laboratory. Driving these products are the reduced costs of producing synthetic nicotine and federal policies that incentivize the use of synthetic nicotine, such as the FDA’s temporary restriction on the sale of certain flavored cartridge-based products. As synthetic nicotine products grow in popularity and market share, public health advocates and policymakers will want to use a comprehensive regulatory approach and research evidence gaps about these addictive products. This 90-minute webinar will cover the availability of these products, what researchers know about the differences between synthetic and tobacco-derived nicotine, consumer perceptions of these products, an overview of the regulatory landscape, and legal solutions.
Dr. David Ashley, PhD, Georgia State University, School of Public Health
Micah Berman, JD, The Ohio State University, College of Public Health, Moritz College of Law
Dr. Brittney Keller-Hamilton, PhD, MPH, The Ohio State University, College of Medicine
Dr. Andrew Seidenberg, PhD, MPH, National Cancer Institute, National Institutes of Health
Patti Zettler, JD, The Ohio State University, Moritz College of Law
Natalie Hemmerich, JD, MPH, Public Health Law Center